ArticleCureus2025
Squamous Eccrine Ductal Carcinoma: A Comprehensive Review of the Clinicopathologic Features and Management in 27 Cases.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Squamoid eccrine ductal carcinoma (SEDC) is a rare cutaneous malignancy that demonstrates both squamous and eccrine differentiation. With a limited number of published cases in the literature, SEDC remains a diagnostic challenge. This retrospective chart review reports on 27 cases of SEDC identified at our institution and summarizes their clinical and histopathologic characteristics. Clinically, these tumors demonstrated a predilection for sun-exposed areas, favoring the head and neck (59.2%, n=16) of older individuals (median age 74 years). They presented as a papule, nodule, or plaque (48.1%, n=13) and were less than 2 cm in size. Despite surgical treatment with either conventional wide local excision or Mohs micrographic surgery, they had a local recurrence rate of 18.5% (n=5). One patient had metastatic disease with local recurrence, regional lymph node involvement, and distant skin metastasis, which led to the patient's death. Given that SEDC histologically exhibits both squamous and eccrine differentiation and immunophenotypically expresses markers of both eccrine/adnexal and squamous origin, this carcinoma poses a diagnostic challenge, as superficial biopsies may be indistinguishable from squamous cell carcinoma. This study emphasizes the importance of recognizing this tumor due to its recurrence risk and potential for metastasis and mortality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.